151 – 160 of 2349
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Boosted production of antibodies which neutralized different SARS-CoV-2 variants in a COVID-19 convalescent following mRNA vaccination - a case study
- Contribution to journal › Article
-
Mark
Insertion of an immunodominant T helper cell epitope within the Group A Streptococcus M protein promotes an IFN-γ-dependent shift from a non-protective to a protective immune response
- Contribution to journal › Article
-
Mark
C4BP(β-)-mediated immunomodulation attenuates inflammation in DSS-induced murine colitis and in myeloid cells from IBD patients
- Contribution to journal › Article
-
Mark
Immunoglobulin germline gene polymorphisms influence the function of SARS-CoV-2 neutralizing antibodies
- Contribution to journal › Article
-
Mark
Galectin-8 Downmodulates TLR4 Activation and Impairs Bacterial Clearance in a Mouse Model of Pseudomonas aeruginosa Keratitis
- Contribution to journal › Article
-
Mark
New methods for phenotypic antibody discovery
(2023) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
-
Mark
Resistance to anti-PD-1/anti-PD-L1 : galectin-3 inhibition with GB1211 reverses galectin-3-induced blockade of pembrolizumab and atezolizumab binding to PD-1/PD-L1
- Contribution to journal › Article
-
Mark
Protective non-neutralizing mAbs Ab94 and Ab81 retain high-affinity and potent Fc-mediated function against SARS-CoV-2 variants from Omicron to XBB1.5
(2023)
- Working paper/Preprint › Preprint in preprint archive
-
Mark
Structural basis of Cfr-mediated antimicrobial resistance and mechanisms for its evasion
(2023)
- Working paper/Preprint › Preprint in preprint archive
-
Mark
Reprogramming Cancer Cells to Antigen-presenting Cells
- Contribution to journal › Article
